Expression and significance of YAP and TAZ proteins in oral squamous cell carcinoma

doi:10.19439/j.sjos.2018.04.016

Abstract

Abstract: PURPOSE: To investigate the expression and significance of YAP and TAZ proteins in oral squamous cell carcinoma. METHODS: From February 2014 to March 2017, 113 oral squamous cell carcinoma specimens were selected, and the adjacent tissues (away from carcinoma > 2 cm) were selected as the control. Immunohistochemical staining was used to detect the expression of YAP and TAZ protein, and its relationship with clinicopathological features were evaluated with SPSS 19.0 software package. RESULTS: The positive rate of YAP and TAZ protein in cancer tissues was 65.49% and 61.95%, respectively, which was significantly higher than that in the adjacent tissues (P<0.05). The positive expression of YAP protein in patients with low differentiation, cervical lymph node metastasis, stage Ⅲ, tumor diameter> 4 cm were 83.64%, 80.33%, 82.35% and 82.61%, significantly higher than that inpatients with high differentiation, without cervical lymph node metastasis, stage I-II, tumor diameter ≤4 cm (P<0.05). The positive expression rate of TAZ protein in patients with low differentiation, stage III, tumor diameter >4 cm was 80%, 85.29% and 82.61%, significantly higher than that in patients with high differentiation, stage I-II, tumor diameter ≤4 cm (P<0.05). The expression of YAP protein was positively correlated with the expression of TAZ protein (r_s=0.571, P<0.05). CONCLUSIONS: YAP and TAZ proteins are strongly expressed in oral squamous cell carcinoma, closely related to the clinical and pathological features such as the degree of differentiation and the diameter of the tumor, suggesting that Hippo signaling pathway may be involved in the development of oral squamous cell carcinoma.

Key words: Oral squamous cell carcinoma, YAP protein, TAZ protein, Hippo signaling pathway

CLC Number:

R739.8

TU Min-song, LI Yi-song, ZHANG Xiong. Expression and significance of YAP and TAZ proteins in oral squamous cell carcinoma[J]. Shanghai Journal of Stomatology, 2018, 27(4): 415-418.

References

[1] 王雪阳, 周昱川, 陈青立, 等. Hippo信号通路相关蛋白YAP, Mst 1, Lats 1/2在口腔鳞癌中的表达及临床意义[J]. 口腔医学研究, 2017, 33(4): 400-403.
[2] 周榕, 石超吉, 韩永, 等. YAP蛋白在口腔鳞癌中的表达及对肿瘤细胞迁移、侵袭的影响[J]. 中国口腔颌面外科杂志, 2016, 14(3): 203-208.
[3] 周昱川, 王雪阳, 陈青立, 等. Hippo信号通路中TAZ、P-TAZ、Mst1/2与P-Mst1/2在口腔鳞状细胞癌中的表达及意义[J]. 肿瘤学杂志, 2017, 23(3):199-204.
[4] 王雪阳, 周昱川, 陈青立, 等. Hippo信号通路相关蛋白YAP,Mst 1,Lats 1/2在口腔鳞癌中的表达及临床意义[J]. 口腔医学研究, 2017, 33(4): 400-403.
[5] 费晨曦, 向学熔, 张华昌, 等. 磷酸酶及张力蛋白同源基因蛋白在口腔鳞状细胞癌中的表达及临床意义[J]. 第三军医大学学报, 2017, 39(1): 79-83.
[6] Dupont S.Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction[J]. Exp Cell Res, 2016, 343(1): 42-53.
[7] 杨磊, 段晓峰. CENP-A在口腔鳞状细胞癌中的表达及意义[J]. 贵阳医学院学报, 2017, 42(5): 566-569.
[8] 郑军, 徐江, 余芯乐, 等. N-乙酰基转移酶10蛋白和朊蛋白在口腔鳞状细胞癌组织中的表达及相关性研究[J]. 口腔医学研究, 2016, 32(5): 483-486.
[9] Xiao H, Jiang N, Zhou B, et al.TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma[J]. Cancer Sci, 2015, 106(2): 151-159.
[10] Zanconato F, Cordenonsi M, Piccolo S.YAP/TAZ at the roots of cancer[J]. Cancer Cell, 2016, 29(6): 783-803.
[11] Hansen CG, Moroishi T, Guan KL.YAP and TAZ: a nexus for Hippo signaling and beyond[J]. Trends Cell Biol, 2015, 25(9): 499-513.
[12] Moroishi T, Hansen CG, Guan KL.The emerging roles of YAP and TAZ in cancer[J]. Nat Rev Cancer, 2015, 15(2): 73-79.
[13] Moroishi T, Park HW, Qin B, et al.A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis[J]. Genes Dev, 2015, 29(12): 1271-1284.
[14] 谭丹, 黎春晖, 聂敏海. 细胞角蛋白19在口腔鳞状细胞癌中的表达及意义[J]. 上海口腔医学, 2016, 25(5): 600-603.
[15] Imajo M, Ebisuya M, Nishida E.Dual role of YAP and TAZ in renewal of the intestinal epithelium[J]. Nat Cell Biol, 2015, 17(1): 7-19.